Eicosanoids and fat emulsions in acute respiratory distress syndrome patients.
Lipid emulsions have been associated with changes in pulmonary function. Although these changes were related to the physical effects of the infusion-induced lipemia on gas exchange, several animal and human studies suggest that the impairment in pulmonary function observed with lipid infusions was mediated by prostaglandins. Prostaglandins are synthesized enzymatically from essential fatty acids. We studied the effects of two lipid emulsions, with different amounts of essential fatty acids (20% long-chain triacylglycerols [LCT] with 55% of linoleic acid and 7% of alpha linolenic acid in 100 g of emulsion, and a physical mixture of 20% medium-chain triacyglycerols [MCT] and LCT with 26% of linoleic acid and 4% of alpha linolenic acid in 100 g of emulsion), on plasma levels of eicosanoids in patients with acute respiratory distress syndrome (ARDS). Although in patients with ARDS, plasma levels of prostanoids were higher than the reference values, neither lipid emulsion, administered at the rate of 2 mg.kg-1.min-1 induced significant changes in the eicosanoids except for a decrease in systemic-pulmonary arterial 6-keto prostaglandin F1 alpha difference.
Planas
M
M
Department of Hematology, Hospital General Vall d'Hebron, Barcelona, Spain.
Masclans
J R
JR
Iglesia
R
R
Porta
I
I
Valls
M
M
Bermejo
B
B
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood / Q000378:metabolism; D000328:Adult; D000368:Aged; D004311:Double-Blind Method; D015777:Eicosanoids / Q000097:blood* / Q000378:metabolism; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage* / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D007975:Leukotriene B4 / Q000097:blood / Q000378:metabolism; D008875:Middle Aged; D010288:Parenteral Nutrition / Q000379:methods*; D011446:Prospective Studies; D012016:Reference Values; D012128:Respiratory Distress Syndrome / Q000097:blood* / Q000378:metabolism / Q000628:therapy; D013929:Thromboxane B2 / Q000097:blood / Q000378:metabolism
D015777:Eicosanoids; D005217:Fat Emulsions, Intravenous; D007975:Leukotriene B4; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha